GGrantIndex
Sort

25,944 grants matching neurodegeneration

GHSR1a and hippocampal pathology in Alzheimer's Disease

$462,920
Heng Du · University Of Texas Dallas · R01 · FY2019 · AG

Identifying peripheral drivers of Alzheimers disease using plasma proteomics

$462,826
Keenan Walker · National Institute On Aging · ZIA · FY2021 · AG

Genetic and molecular correlates of white matter pathology in Alzheimers disease

$462,691
Julia K Kofler · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG

Alzheimer's tauopathy phenotype and the microRNA22-3p: implication for pathogenesis

$462,655
Domenico Pratico · Temple Univ Of The Commonwealth · R01 · FY2021 · AG

Investigation of impaired neural stem cell activation in Alzheimer's Disease

$462,646
Ashley E Webb · Buck Institute For Research On Aging · R01 · FY2024 · AG

Mitochondrial Zn2+ accumulation and the induction of ischemic neurodegeneration

$462,615
John H Weiss · University Of California-Irvine · R56 · FY2018 · NS

Peripheral BDZ Receptor - Biomarker of Neurotoxicity

$462,605
Tomas R Guilarte · Florida International University · R01 · FY2022 · ES

Peripheral BDZ Receptor - Biomarker of Neurotoxicity

$462,604
Tomas R Guilarte · Florida International University · R01 · FY2021 · ES

Peripheral BDZ Receptor - Biomarker of Neurotoxicity

$462,604
Tomas R Guilarte · Florida International University · R01 · FY2020 · ES

High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease

$462,524
Jun Wang · State University New York Stony Brook · R21 · FY2022 · AG

Chemical approaches for targeting ribonucleoprotein assemblies

$462,500
Tommaso Cupido · St. Jude Children'S Research Hospital · R35 · FY2024 · GM

Chemical approaches for targeting ribonucleoprotein assemblies

$462,500
Tommaso Cupido · St. Jude Children'S Research Hospital · R35 · FY2025 · GM

Neuronal responses to chronic demyelination

$462,479
Ben Emery · Oregon Health & Science University · R01 · FY2022 · NS

Peripheral BDZ Receptor - Biomarker of Neurotoxicity

$462,343
Tomas R Guilarte · Florida International University · R01 · FY2019 · ES

Biomarkers in Aging, MCI and Alzheimer's Disease

$462,219
University Of California San Diego · R01 · FY2003 · AG

Molecular and genetic studies of NMNAT2 in neuroprotection

$462,158
Hui-Chen Lu · Trustees Of Indiana University · R01 · FY2025 · NS

Role of Rab27b in synucleinopathies

$462,037
Talene Alene Yacoubian · University Of Alabama At Birmingham · R01 · FY2024 · NS

Non-apoptotic neural stem cell loss

$462,000
Kristin White · Massachusetts General Hospital · R21 · FY2020 · NS

Regulation of Neuronal Clearance Pathways via Nuclear Calcium Signaling in Alzheimer's Disease

$461,942
Wilma J Friedman · Rutgers The State Univ Of Nj Newark · R01 · FY2021 · AG

REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING

$461,875
Fabio Demontis · St. Jude Children'S Research Hospital · R01 · FY2024 · AG

Title: Development and Validation of Therapy for GM1 Gangliosidosis

$461,701
Jillian R Brown · Tega Therapeutics, Inc. · R43 · FY2023 · NS

Gene Expression in Long-term Memory

$461,610
Cristina M Alberini · New York University · R01 · FY2011 · MH

CORE A: Administrative Core

$461,401
Jefferson Kinney · Cleveland Clinic Foundation · P20 · FY2021 · GM

Hypoperfusion, Hemodynamic Control Domains and Neurovascular Dysregulation in AD brain pathology

$461,400
Dennis Alan Turner · Duke University · R01 · FY2024 · AG

Characterization of CNS protein aggregate components during acute and chronic EAE

$461,389
Bridget Shafit-Zagardo · Albert Einstein College Of Medicine · R21 · FY2020 · NS